The Epidermal Growth Factor Receptor as a Therapeutic Target in Glioblastoma Multiforme and other Malignant Neoplasms

Erstveröffentlichung
2009Authors
Loew, Sarah
Schmidt, Ursula I.
Unterberg, Andy
Halatsch, Marc-Eric
Wissenschaftlicher Artikel
Published in
Anti-Cancer Agents in Medicinal Chemistry ; 9 (2009), 6. - S. 703-715. - ISSN 1871-5206. - eISSN 1875-5992
Link to publication
https://dx.doi.org/10.2174/187152009788680019Institutions
UKU. Klinik für NeurochirurgieSubject headings
[Free subject headings]: Epidermal growth factor receptor | glioblastoma multiforme | erlotinib | gefitinib | cetuximab | tyrosine kinase inhibitors | anti-EGFR monoclonal antibodies | CELL LUNG-CANCER | TYROSINE KINASE INHIBITOR | PHASE-I/II TRIAL | HIGH-GRADE GLIOMA | MONOCLONAL-ANTIBODY | BREAST-CANCER | RADIATION-THERAPY | BRAIN-TUMORS | EGF RECEPTOR | IN-VITRO[DDC subject group]: DDC 540 / Chemistry & allied sciences | DDC 610 / Medicine & health